McKesson, CD&R Near $5 Billion-Plus Deal to Buy Option Care, FT Reports
The acquisition would expand McKesson’s healthcare services footprint as Option Care shares rose 21% in extended trading, according to the report.
7 Articles
7 Articles
McKesson, CD&R near $5 billion-plus deal to buy Option Care ...
McKesson and CD&R close in on $5bn-plus acquisition of Option Care Health
McKesson and Clayton Dubilier & Rice are nearing an agreement to acquire Option Care Health, the largest independent provider of infusion services in the US, in a transaction that would value the healthcare company at more than $5bn including debt, according to a report by the Financial Times.
CD&R and McKesson Corporation Sign Agreement to Acquire Option Care Health
NEW YORK & IRVING, Texas & BANNOCKBURN, Ill.--(BUSINESS WIRE)--CD&R, McKesson Corporation (NYSE: MCK) (“McKesson”), and Option Care Health, Inc. (Nasdaq: OPCH) (“Option Care Health”) announced today that they have entered into a definitive agreement, under which CD&R and McKesson will acquire Option Care Health, an independent provider of home and alternate site infusion services, for $32.05 per share, reflecting a total enterprise value of appr…
Coverage Details
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
